Design, synthesis and bioactivities evaluation of novel oleanolic acid derivatives as potent PI3K inhibitors

被引:1
|
作者
Song, Yan-Ling [1 ]
Zhu, Ming-Xia [1 ]
Wang, Hai-Feng [1 ]
Meng, Yan-Qiu [1 ]
机构
[1] Shenyang Univ Chem Technol, Dept Pharmaceut Engn, Shenyang 110142, Peoples R China
基金
中国国家自然科学基金;
关键词
Oleanolic acid derivative; PI3K inhibitor; antitumor activity; ANTITUMOR-ACTIVITY;
D O I
10.1080/10286020.2022.2066528
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Oleanolic acid has previously been shown to possess PI3K inhibitory activity, thus, the purpose of this work was to generate a series of derivatives that improve the potency. Twenty rationally designed oleanolic acid derivatives were synthesized and tested the cytotoxicity and PI3K inhibitory activity. The results suggested that attachment of additional structural elements such as association of thiazole group to A ring and insertion of phenylurea group was important for increasing activities. The most active derivative was compound II2, which exhibited PI3K inhibitory activity (IC50 = 58.42 nmol/l) and improved interaction with activity site of PI3K according with docking studies.
引用
收藏
页码:264 / 276
页数:13
相关论文
共 50 条
  • [21] Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ
    Sha, Shao
    Han, Hong-Wei
    Gao, Fei
    Liu, Tian-Bao
    Li, Zhen
    Xu, Chi
    Zhong, Wei-Qing
    Zhu, Hai-Liang
    MEDCHEMCOMM, 2015, 6 (11) : 2029 - 2035
  • [22] Synthesis and discovery of mitochondria-targeting oleanolic acid derivatives for potential PI3K inhibition
    Li, Yi
    Zeng, Qingqing
    Wang, Rui
    Wang, Bo
    Chen, Ruofan
    Wang, Na
    Lu, Yiru
    Shi, Fangwen
    Dehaen, Wim
    Huai, Qiyong
    FITOTERAPIA, 2022, 162
  • [23] Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Wu, Peng
    Su, Yi
    Guan, Xianghong
    Liu, Xiaowen
    Zhang, Jiankang
    Dong, Xiaowu
    Huang, Wenhai
    Hu, Yongzhou
    PLOS ONE, 2012, 7 (08):
  • [24] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
    Jia, Hong
    Dai, Guangxiu
    Su, Weiguo
    Xiao, Kun
    Weng, Jianyang
    Zhang, Zhulin
    Wang, Qing
    Yuan, Tianhai
    Shi, Fuying
    Zhang, Zheng
    Chen, Wei
    Sai, Yang
    Wang, Jian
    Li, Xiong
    Cai, Yu
    Yu, Jun
    Ren, Ping
    Venable, Jennifer
    Rao, Tadimeti
    Edwards, James P.
    Bembenek, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
  • [25] Synthesis and anticancer evaluation of novel 1 H -benzo[ d ]imidazole derivatives of dehydroabietic acid as PI3K? inhibitors
    Yang, Ya-Qun
    Chen, Hao
    Liu, Qing-Song
    Sun, Yue
    Gu, Wen
    BIOORGANIC CHEMISTRY, 2020, 100
  • [26] Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors
    Rady, Ghada S.
    El Deeb, Moshira A.
    Sarg, Marwa T. M.
    Taher, Azza T.
    Helwa, Amira A.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (02): : 733 - 752
  • [27] Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors
    Lv, Xiaoqing
    Ying, Huazhou
    Ma, Xiaodong
    Qiu, Ni
    Wu, Peng
    Yang, Bo
    Hu, Yongzhou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 99 : 36 - 50
  • [28] Design, synthesis and in vitro biological evaluation of 2-aminopyridine derivatives as novel PI3Kδ inhibitors for hematological cancer
    Yang, Chengbin
    Gong, Yimin
    Gao, Yunjian
    Deng, Mingli
    Liu, Xiaofeng
    Yang, Yongtai
    Ling, Yun
    Jia, Yu
    Zhou, Yaming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 82
  • [29] Design, synthesis and biological evaluation of novel selective PI3Kδ inhibitors containing pyridopyrimidine scaffold
    Ma, Mengyan
    Feng, Yifan
    Zhang, San-Qi
    Duan, Weiming
    Gao, Li
    Yuan, Bo
    Xin, Minhang
    FUTURE MEDICINAL CHEMISTRY, 2023, 15 (16) : 1491 - 1509
  • [30] Design, synthesis, and biological evaluation of novel bivalent PI3K inhibitors for the potential treatment of cancer
    Xia, Liang
    Jiang, Lin
    Du, Tingting
    Lin, Songwen
    Xiong, Tianning
    Peng, Shouguo
    Tian, Hua
    Zhang, Kehui
    Wu, Deyu
    Sheng, Li
    Ji, Ming
    Chen, Xiaoguang
    Xu, Heng
    BIOORGANIC CHEMISTRY, 2023, 140